跳至主要内容
临床试验/NCT00000331
NCT00000331撤回2 期

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3

University of Colorado, Denver1 个研究点 分布在 1 个国家开始时间: 2002年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
试验地点
1
主要终点
Observed withdrawal rating

研究概览

简要总结

The purpose of this study is to assess the abuse liability and examine the reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in healthy, non-drug dependent volunteers.

详细描述

not available at this time

研究设计

研究类型
Interventional
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals must be healthy, non-drug dependent volunteers, be at least 18 years of age, and have no prior history of drug or alcohol abuse or dependence. Subjects must have had some minimal experience with opioids (e.g. at least two prior exposures)

排除标准

  • Individuals with evidence of an active Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness, organic psychiatric disorders), significant medical illness (e.g., liver or cardiovascular disease) or pregnant female subjects are excluded from study participation.

研究组 & 干预措施

Test Drug

Experimental

Test drug to prevent heroine withdrawal

干预措施: Test Drug (Drug)

Placebo Pill

Placebo Comparator

Placebo drug

干预措施: Placebo Drug (Drug)

结局指标

主要结局

Observed withdrawal rating

Drug effect characteristics

Pupil diameter

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验